This retrospective observational study aims to evaluate the association between neck tumor burden and high-risk imaging features with locoregional recurrence and distant metastasis in patients with stage N3 nasopharyngeal carcinoma, and to explore the potential benefits of neck dissection, with or without re-irradiation or systemic therapy, in improving regional control and survival. The key questions addressed are whether high N burden and high-risk imaging features are significantly correlated with neck recurrence and distant metastasis, and whether salvage neck treatment (such as neck dissection ± re-irradiation/systemic therapy) can improve regional control and survival outcomes in this high-risk population.
Nasopharyngeal carcinoma (NPC), due to its anatomical proximity to the skull base and critical cervical structures, is primarily treated with radiotherapy. However, even with current standard treatments, a subset of patients still develop locoregional failure with poor outcomes. Previous data have shown that the 5-year locoregional control rate for stage IV disease is approximately 80.7%, corresponding to a failure rate of about 20%. Among these, patients with T1-4N3 disease have a lower 3-year distant failure-free survival compared with T4N0-2, indicating that high N stage is associated not only with regional recurrence but also with increased risk of distant metastasis. Based on this, we hypothesize that high nodal burden and high-risk imaging features are significantly associated with cervical recurrence and distant metastasis, and that appropriate and timely salvage treatment to the neck (such as neck dissection with or without re-irradiation/systemic therapy) may improve regional control and survival.
Study Type
OBSERVATIONAL
Enrollment
7
Salvage neck treatment, including neck dissection with or without re-irradiation and/or systemic therapy, administered to patients with stage N3 nasopharyngeal carcinoma after completion of definitive concurrent chemoradiotherapy (CCRT) or induction chemotherapy followed by radiotherapy/CCRT.
Taichung Veterans General Hospital
Taichung, Taiwan
Progression-Free Survival (PFS)
PFS is defined as the time from treatment completion to the first documented disease progression (locoregional recurrence or distant metastasis) or death, whichever occurs first.
Time frame: From completion of primary treatment (CCRT or induction chemotherapy plus RT/CCRT) to disease progression, recurrence, or death from any cause, up to 5 years.
Overall Survival (OS)
OS is defined as the duration from treatment completion until death from any cause.
Time frame: From treatment completion to death from any cause, up to 5 years.
Locoregional Recurrence-Free Survival (LRRFS)
LRRFS is defined as the time from treatment completion to the first documented local or regional recurrence.
Time frame: From treatment completion to the first occurrence of locoregional recurrence, up to 5 years.
Patterns of Failure
Documenting the site and timing of failure (local, regional, distant) based on imaging and pathology reports.
Time frame: From treatment completion to recurrence/metastasis, up to 5 years.
Adverse Events of Salvage Treatment
Acute and late adverse events related to salvage neck dissection, re-irradiation, or systemic therapy, graded according to CTCAE v5.0.
Time frame: From initiation of salvage therapy to 90 days post-treatment.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.